65 security-"https:"-"https:"-"https:"-"https:"-"Dr" positions at Zintellect in United States
Sort by
Refine Your Search
-
, and cellular and gene therapies. Research Project: CBER’s mission is to ensure the safety, purity, potency, and effectiveness of biological products including vaccines, blood and blood products, and
-
, and cellular and gene therapies. Research Project: CBER’s mission is to ensure the safety, purity, potency, and effectiveness of biological products including vaccines, blood and blood products, and
-
laboratory has been conducting collaborative research on the evaluation of safety and efficacy characteristics of live attenuated Leishmania parasite strains (LmCen-/- and LmexCen-/-) using several pre
-
research that secures the nation’s food supply, agricultural economy, and environmental health against the threat of invasive foreign plant diseases and weeds. Research Project: You will join a team focused
-
information on the opportunity to which you have applied, as well as a secure link to submit a recommendation for you for this application. If you ask the same person to submit a recommendation for you for
-
. These efforts cover more than just medicines. Research Project: This research aims to leverage advanced technologies such as AI agents for causality assessments of individual case safety reports. Participation is
-
. Contingencies All awards and active participation in the program are contingent upon security access approval to Oak Ridge National Laboratory, agreement with the Terms of Appointment, and completion of all
-
. Application Deadline 3/31/2026 6:00:00 PM Eastern Time Zone Description THE INTELLIGENCE COMMUNITY POSTDOCTORAL RESEARCH FELLOWSHIP PROGRAM: TRANSFORMING SCIENTIFIC DISCOVERY INTO NATIONAL SECURITY ADVANTAGE
-
will also consider fire exposure risk, erosion, nearshore coral health, and health and human safety. This learning opportunity will involve mentorship into how to construct complex landscape scale
-
scientific and regulatory knowledge of microbiological science and adventitious agent safety for both pharmaceuticals and therapeutic proteins, offering opportunities for collaboration with FDA scientists